News Archives - Page 192 of 747

TuesdayJul 11, 2023 9:45 am

Starco Brands, Inc. (STCB) Partners with AMC to Launch Cardi B’s Whipshots(R) at 250+ Theatres Nationwide

Starco Brands partners with AMC to offer Whipshots(R) Vanilla or Lime flavors to cocktails at 250+ theatres across the United States Partnership to include “Whip It, Beaches” campaign spot before selected films and imagery throughout theaters Whipshots earned several awards, including Beverage Dynamics’ 2023 “Rising Star Award”, 2023 SIP Innovation Award, and four medals at the DB & SB Spring Blind Tasting segment of the 2023 Global Spirits Masters Competition Starco Brands 2022 year-end financial statements revealed a 1,060% revenue increase to $7.8 million Other Starco Brands products include Kobe Bryant’s Art of Sport premium athletic body care line, Skylar…

TuesdayJul 11, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) – A Zacks Update

Lexaria just released its mid-year update, highlighting its key milestones so far and its objectives going forward, summarized in a recent Zacks update Of note was the company’s most ambitious clinical study yet, HYPER-H21-4, along with its growing patent portfolio that now sees six additional patents awarded across Australia, Japan, the U.S., and Canada so far in 2023 The company also noted its $2 million capital raise back in May, a strong indicator of shareholders’ confidence in the brand, and its efforts to grow its operations Lexaria looks to build on the momentum gathered so far, and its management is…

MondayJul 10, 2023 11:15 am

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Is ‘One to Watch’

First Tellurium in June 2023 successfully uplisted from the OTC Pink Market to the OTCQB Venture Market First Tellurium has contracted for IP geophysics on its Deer Horn Project during summer 2023 to develop targets for a drilling program The company has engaged consultants to stake additional claims around its Klondike gold-tellurium project in Colorado Key applications for tellurium include high efficiency cadmium telluride solar panels, next-gen lithium-ion batteries, semiconductors, thermoelectric devices, phase-change memory chips and low-energy desalination The company plans to investigate and acquire other tellurium projects in North America First Tellurium (CSE: FTEL) (OTCQB: FSTTF) is committed to…

MondayJul 10, 2023 10:30 am

D-Wave Quantum Inc. (NYSE: QBTS) Technology Ready to Answer Call of Proposed Legislation for Near-Term Quantum Applications to Solve Optimization Problems

Legislation presented to Congress calls for the United States government to develop and adopt near-term quantum computing – some within 24 months or less for developing and deploying demos, proofs of concepts, and pilots Global government spending on quantum application development is expected to reach $36 billion during 2023 D-Wave offers quantum solutions to help government and public sector develop applications that can solve important optimization problems Recent legislation presented to Congress calls for the United States government to develop and adopt near-term quantum computing applications to solve complex public sector optimization problems, which could include electrical grid resilience, optimization…

MondayJul 10, 2023 9:45 am

Data443 Risk Mitigation Inc. (ATDS) Upgrades Product Offering; Committed to Enabling Businesses to Manage Data Privacy in Cloud, Hybrid Environments

Data is one of the most valuable and critical assets for today's businesses, but with cyber-attacks on the rise it can quickly become one of their greatest liabilities Alarming statistics reveal that the number of security executives reporting security incidents in software-as-a-service environments surged from 43% to 55% over the past two years, with data leakage as the most common type of security incident, followed by malicious apps, data breaches, and ransomware Amid the current climate of ongoing data breach news, Data443 Risk Mitigation aims to cement its position as the provider of "All Things Data Security" by continuing to…

MondayJul 10, 2023 9:00 am

Genprex Inc. (NASDAQ: GNPX) Reports Positive Results from its Phase 1 Acclaim-1 Clinical Trial; Releases Patient Video Describing Positive Experience

Genprex recently announced that its lead drug candidate, REQORSA(R), was well tolerated with no dose-limiting toxicities in the Phase 1 portion of its Acclaim-1 clinical trial The Phase 1 clinical data were added to by the release of a new patient video highlighting a patient’s experience with REQORSA. This patient has now been on the Acclaim-1 trial without disease progression for one year The Safety Review Committee approved the advancement of the Acclaim 1 clinical trial to the Phase 2 expansion portion of the trial Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients…

FridayJul 07, 2023 9:45 am

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) Is ‘One to Watch’

Reunion Gold is a leading gold explorer in South America’s Guiana Shield, a highly prospective and relatively underexplored region. The company’s Oko West Project in Guyana comprises a prospecting license with an area of approximately 44 square kilometers and is 100% held by Reunion through its local subsidiary. Guyana is recognized as a mining-friendly jurisdiction and in 2022 its ranking by the Fraser Institute ranking of mining investment attractiveness increased to 22nd ranked areas in the world and the top country in south America. The company’s leadership boasts over 225 years of combined experience in the Guiana Shield. On June…

FridayJul 07, 2023 9:00 am

Electronic Servitor Publication Network Inc. (XESP) Shows How Their Disruptive Technology and Processes Drive the Results CEOs are Demanding

XESP is a market disruptor offering cutting-edge data analysis and intelligent technology to help companies reach their target markets The company’s Digital Engagement Engine(TM) technology platform provides clients with meaningful connections that guide their audiences from awareness to action Electronic Servitor Publication Network’s disruptive solution helps clients maintain complete control of their content while dynamically connecting with current and new audiences to drive growth Electronic Servitor Publication Network (OTCQB: XESP) is a market disruptor focused on connecting companies with target audiences to drive predictable growth. XESP’s managed service provides B2B clients with cutting-edge data analysis and intelligent technology to help…

ThursdayJul 06, 2023 9:45 am

Starco Brands, Inc. (STCB) Announces Collaboration Between Skylar Fragrance Division and Amazon Prime Video

Skylar recently announced a collaboration with Amazon Prime Video as the official fragrance of “The Summer I Turned Pretty” series To celebrate the partnership, Skylar released three rollerball fragrances featuring “The Summer I Turned Pretty” branding: Salt Air, Boardwalk Delight, and Capri Summer Skylar fragrances are cruelty-free, vegan, hypoallergenic, and formulated without any of the 36 known perfume allergens or 1,300+ “questionable” ingredients Starco Brands, Inc. is an invention factory that invents or acquires innovative products with behavior-changing technologies and leverages an extensive network of manufacturing, distribution, and media partners Other Starco Brands include the Art of Sport premium skincare…

ThursdayJul 06, 2023 9:00 am

Genprex, Inc. (NASDAQ: GNPX) Receives Third Fast Track Designation for REQORSA(R), Setting Stage for Commencement of Acclaim-3 Clinical Trial in Q3

Genprex recently received a Fast Track Designation (“FTD”) from the FDA for its REQORSA(R) Immunogene Therapy in combination with Genentech, Inc.’s Tecentriq(R) in patients with extensive-stage small cell lung cancer This is Genprex’s third FTD and sets the stage for the initiation of its third lung cancer clinical trial, Acclaim-3 Acclaim-3 clinical trial is a Phase 1/2 dose escalation and clinical response study of maintenance therapy evaluating REQORSA in combination with Tecentriq The company expects to enroll the first patient in its Acclaim-3 clinical trial in the third quarter of 2023 Genprex is combining its lead product candidate, REQORSA, with…

Site Search

Company Search

Category: News